Cell Aging Triggered by Mitochondria

An international team of scientists has for the first time shown that mitochondria, the batteries of the cells, are essential for ageing.

In a study, published today in the EMBO Journal and led by Dr João Passos at Newcastle University, they found that when mitochondria were eliminated from ageing cells they became much more similar to younger cells. This experiment was able for the first time to conclusively prove that mitochondria are major triggers of cell ageing.

This brings scientists a step closer to developing therapies to counteract the ageing of cells, by targeting mitochondria.

Defying ageing in the cell

As we grow old, cells in our bodies accumulate different types of damage and have increased inflammation, factors which are thought to contribute to the ageing process.

The team carried out a series of genetic experiments involving human cells grown in the laboratory and succeeded in eliminating the majority, if not all, the mitochondria from ageing cells. Cells can normally eliminate mitochondria which are faulty by a process called mitophagy. The scientists were able to “trick” the cells into inducing this process in a grand scale, until all the mitochondria within the cells were physically removed.

To their surprise, they observed that the ageing cells, after losing their mitochondria, showed characteristics similar to younger cells, that is they became rejuvenated. The levels of inflammatory molecules, oxygen free radicals and expression of genes which are among the makers of cellular ageing dropped to the level that would be expected in younger cells.

New thinking on mitochondria

Dr João Passos of the Institute for Ageing said: “This is a very exciting and surprising discovery. We already had some clues that mitochondria played a role in the ageing of cells, but scientists around the world have struggled to understand exactly how and to what extent these were involved.

Image shows a labelled diagram of mitochondria.
Researchers identified that as cells grow old, mitochondrial biogenesis, the complex process by which mitochondria replicate themselves, is a major driver of cellular ageing. Image is for illustrative purposes only.

“These new findings highlight that mitochondria are actually essential to the ageing of cells.”

The team led by Newcastle University and involving other universities in the UK and the US, also deciphered a new mechanism by which mitochondria contribute to ageing. They identified that as cells grow old, mitochondrial biogenesis, the complex process by which mitochondria replicate themselves, is a major driver of cellular ageing.

“This is the first time that a study demonstrates that mitochondria are necessary for cellular ageing,” said Dr Clara Correia-Melo of the Newcastle University Institute for Ageing and the lead author of the study. “Now we are a step closer to devising therapies which target mitochondria to counteract the ageing of cells.”

About this genetics and aging research

Funding: This work was funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and is part of Newcastle University’s response to the challenges and opportunities presented by an ageing population. Newcastle University is a world leader in the field at its Campus for Ageing and Vitality which is supported by the National Institute for Health Research (NIHR) Biomedical Research Centre and the location for a new £40m National Centre for Ageing Science and Innovation (NASI).

Source: Newcastle University
Image Source: The image is in the public domain
Original Research: Full open access research for “Mitochondria are required for pro‐ageing features of the senescent phenotype” by Clara Correia‐Melo, Francisco DM Marques, Rhys Anderson, Graeme Hewitt, Rachael Hewitt, John Cole, Bernadette M Carroll, Satomi Miwa, Jodie Birch, Alina Merz, Michael D Rushton, Michelle Charles, Diana Jurk, Stephen WG Tait, Rafal Czapiewski, Laura Greaves, Glyn Nelson, Mohammad Bohlooly‐Y, Sergio Rodriguez‐Cuenca, Antonio Vidal‐Puig, Derek Mann, Gabriele Saretzki, Giovanni Quarato, Douglas R Green, Peter D Adams, Thomas von Zglinicki, Viktor I Korolchuk, and João F Passos in EMBO Journal. Published online February 4 2016 doi:10.15252/embj.201592862


Abstract

Mitochondria are required for pro‐ageing features of the senescent phenotype

Cell senescence is an important tumour suppressor mechanism and driver of ageing. Both functions are dependent on the development of the senescent phenotype, which involves an overproduction of pro‐inflammatory and pro‐oxidant signals. However, the exact mechanisms regulating these phenotypes remain poorly understood. Here, we show the critical role of mitochondria in cellular senescence. In multiple models of senescence, absence of mitochondria reduced a spectrum of senescence effectors and phenotypes while preserving ATP production via enhanced glycolysis. Global transcriptomic analysis by RNA sequencing revealed that a vast number of senescent‐associated changes are dependent on mitochondria, particularly the pro‐inflammatory phenotype. Mechanistically, we show that the ATM, Akt and mTORC1 phosphorylation cascade integrates signals from the DNA damage response (DDR) towards PGC‐1β‐dependent mitochondrial biogenesis, contributing to a ROS‐mediated activation of the DDR and cell cycle arrest. Finally, we demonstrate that the reduction in mitochondrial content in vivo, by either mTORC1 inhibition or PGC‐1β deletion, prevents senescence in the ageing mouse liver. Our results suggest that mitochondria are a candidate target for interventions to reduce the deleterious impact of senescence in ageing tissues.

“Mitochondria are required for pro‐ageing features of the senescent phenotype” by Clara Correia‐Melo, Francisco DM Marques, Rhys Anderson, Graeme Hewitt, Rachael Hewitt, John Cole, Bernadette M Carroll, Satomi Miwa, Jodie Birch, Alina Merz, Michael D Rushton, Michelle Charles, Diana Jurk, Stephen WG Tait, Rafal Czapiewski, Laura Greaves, Glyn Nelson, Mohammad Bohlooly‐Y, Sergio Rodriguez‐Cuenca, Antonio Vidal‐Puig, Derek Mann, Gabriele Saretzki, Giovanni Quarato, Douglas R Green, Peter D Adams, Thomas von Zglinicki, Viktor I Korolchuk, and João F Passos in EMBO Journal. Published online February 4 2016 doi:10.15252/embj.201592862

Feel free to share this Neuroscience News.
Join our Newsletter
I agree to have my personal information transferred to AWeber for Neuroscience Newsletter ( more information )
Sign up to receive our recent neuroscience headlines and summaries sent to your email once a day, totally free.
We hate spam and only use your email to contact you about newsletters. You can cancel your subscription any time.
  1. The spice turmeric that contains curcuminoids,even in small and safe doses has good effectiviness(1)as an inhibitor of mTORC1.Then turmeric can works as a biochemical and pharmacological safe basis to develops others byproducts with the same mechanisms of action of turmeric,but with a higher effectiviness.About PGC‐1β, instead to deletion, there are more physiological and safe ways to delay or to control ageing,as the with high effectiiviness of the nutraceutical supplement Acetyl L Carnitine (so called ALCAR),once ALCAR treatment is able to reverse the age-associated decline of PGC-1α, PGC-1β (2). And ALCAR limit age-linked mitochondrial decay in brain,by increasing mitochondrial efficiency, and reversing the age-related alterations of mitochondrial proteins (3).
    1) Mol Cancer Ther. 2008-Curcumin Inhibits Akt/mTOR Signaling Through Protein Phosphatase-Dependent Mechanism-Siwang Yu
    2) Rejuvenation Res. 2012 -Acetyl-L-Carnitine Activates the Peroxisome Proliferator-Activated Receptor-γ Coactivators PGC-1α/PGC-1β-Dependent Signaling Cascade of Mitochondrial
    3) J Proteomics. 2011- Rat Liver Mitochondrial Proteome: Changes Associated With Aging and Acetyl-L-Carnitine Treatment. Musicco C

Comments are closed.